Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market
I'm PortAI, I can summarize articles.
Sunshine Biopharma said Monday its Canadian unit Nora Pharma has launched a generic version of Everolimus in Canada. The company said the drug is a substitute for Afinitor and is used to treat certain types of cancer, including advanced kidney cancer, certain breast cancers, and specific neuroendocrine tumors. The product is available in 2.5 mg, 5 mg, and 10 mg tablet doses, Sunshine said. Shares of the company were up more than 16% in recent Monday premarket activity.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments